Swedish Orphan Biovitrum Forecast, price target & analysts
Swedish Orphan Biovitrum Target price 2026 - Analyst rating & recommendation
Swedish Orphan Biovitrum Classifications & Recommendation
Swedish Orphan Biovitrum Price Target
| Target Price | kr517.65 |
| Price | kr436.20 |
| Potential |
18.67%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Swedish Orphan Biovitrum 2027 .
The average Swedish Orphan Biovitrum target price is kr517.65.
This is
18.67%
register free of charge
kr619.50
42.02%
register free of charge
kr353.50
18.96%
register free of charge
|
|
| A rating was issued by 19 analysts: 13 Analysts recommend Swedish Orphan Biovitrum to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Swedish Orphan Biovitrum stock has an average upside potential 2027 of
18.67%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 28.24 | 33.76 |
| 8.50% | 19.57% | |
| EBITDA Margin | 40.85% | 38.66% |
| 11.77% | 5.37% | |
| Net Margin | 1.69% | 21.18% |
| 88.66% | 1,151.22% |
15 Analysts have issued a sales forecast Swedish Orphan Biovitrum 2026 . The average Swedish Orphan Biovitrum sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Swedish Orphan Biovitrum EBITDA forecast 2026. The average Swedish Orphan Biovitrum EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Swedish Orphan Biovitrum Analysts have issued a net profit forecast 2026. The average Swedish Orphan Biovitrum net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 1.38 | 20.59 |
| 87.72% | 1,392.03% | |
| P/E | 21.18 | |
| EV/Sales | 4.94 |
16 Analysts have issued a Swedish Orphan Biovitrum forecast for earnings per share. The average Swedish Orphan Biovitrum EPS is
This results in the following potential growth metrics and future valuations:
Swedish Orphan Biovitrum...
Current Swedish Orphan Biovitrum Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Sep 10 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 04 2026 |
| BNP PARIBAS |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Jul 20 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Sep 10 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 04 2026 |
|
Locked
BNP PARIBAS:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Jul 20 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 17 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 14 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
